-
In women with threatened preterm labor, sonographic measurement of cervical length helps distinguish between true and false labor.
-
Umbilical artery Doppler as a screening test for fetal well-being in a high-risk population was associated with a decreased incidence of cesarean delivery for fetal distress compared to the nonstress testing, with no increase in neonatal morbidity.
-
Twelve cycles of single-agent paclitaxel administered to women with advanced ovarian cancer who attain a clinically defined complete response to initial platinum/paclitaxel-based chemotherapy significantly prolongs the duration of progression-free survival.
-
The WHI and the WELL-HART clinical trials report that hormone therapy does not reduce the risk of coronary events or slow the progression of atherosclerosis in older women.
-
Prolapse occurs along a spectrum from early and asymptomatic to advanced and symptomatic. The authors define anatomic cutoffs that are likely to result in symptomatic and clinically significant prolapse.
-
Barriers to guideline-adherent care for advanced ovarian cancer are impacted by geographic proximity to a high-volume hospital and travel distance. However, these geographic barriers disproportionately affect racial minorities and women of lower socioeconomic status.
-
In this prospective cohort study of 161 nulligravid women, there was no reliable threshold of uterine length or flexion angle measurements that were predictive of painful or difficult insertions. History of severe dysmenorrhea was the only predictor of insertion pain.
-
News from the KEEPS Study: HRT Does Not Decrease Progression of Atherosclerosis Over 4 Years of Treatment
-
The authors randomized women with objectively validated heavy menstrual bleeding (mean menstrual blood loss [MBL] of 80 mL or more per cycle, confirmed using the alkaline hematin methodology during two pretreatment cycles) to treatment with oral tranexamic acid 3.9 g/d or placebo for up to 5 days per cycle for 6 menstrual cycles.
-
The rate of sepsis with group b streptococcus (gbs) in neonates of colonized mothers is now less than 1%.